D. E. Shaw & Co., Inc. Magenta Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $33,983 - $107,907	35,035 Added 194.74%	53,026 $64,000
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $45,877 - $94,092	17,991 New	17,991 $52,000
Q4 2018 Feb 14, 2019	SELL	$5.57 - $11.65 $99,452 - $208,010	-17,855 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $202,118 - $280,323	17,855 New	17,855 $214,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.